- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07226921
Language Control Across Modalities
November 7, 2025 updated by: Chuchu Li, University of California, San Diego
Language Control Across Comprehension and Production in Unimodal and Bimodal Bilinguals
This study aims to investigate how unimodal bilinguals who speak two languages and bimodal bilinguals who speak one language and sign another control languages across comprehension and production.
Participants will complete different language tasks (e.g., classify a word, name a picture) in different languages, and their behavioral performance will be assessed, including accuracy and reaction time.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
360
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92037
- Recruiting
- UCSD
-
Contact:
- Chuchu Li
- Phone Number: 619-543-5221
- Email: chl441@health.ucsd.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Proficient in both Mandarin and English, or proficiency in both ASL and English
Exclusion Criteria:
- Know a third language better than Mandarin/English or better than ASL/English
- With language disorder or other neurological disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Predictable one-language production & both-language comprehension
|
Whether the task of the next trial (comprehension or production) is predictable
whether both languages or only one language is involved in the current block
|
|
Experimental: Predictable both-language production & both-language comprehension
|
Whether the task of the next trial (comprehension or production) is predictable
whether both languages or only one language is involved in the current block
|
|
Experimental: Unpredictable one-language production & both-language comprehension
|
Whether the task of the next trial (comprehension or production) is predictable
whether both languages or only one language is involved in the current block
|
|
No Intervention: Single language comprehension and production
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Switch costs in different contexts
Time Frame: An average of one year for each condition
|
An average of one year for each condition
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 6, 2025
Primary Completion (Estimated)
May 31, 2030
Study Completion (Estimated)
July 31, 2030
Study Registration Dates
First Submitted
November 6, 2025
First Submitted That Met QC Criteria
November 7, 2025
First Posted (Actual)
November 12, 2025
Study Record Updates
Last Update Posted (Actual)
November 12, 2025
Last Update Submitted That Met QC Criteria
November 7, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 806634
- R01HD116841 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.